You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 5, May 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (35)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Radiation Therapy
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Alert me on articles by topic

Eating and Weight Changes Following Chemoradiation Therapy for Advanced Head and Neck Cancer

Lisa A. Newman, ScD; Francisco Vieira, MD; Valerie Schwiezer, MD; Sandeep Samant, MD; Thomas Murry, PhD; Gayle Woodson, MD; Parvesh Kumar, MD; K. Thomas Robbins, MD

Arch Otolaryngol Head Neck Surg. 1998;124:589-592.

Objective  To describe the functional outcomes of weight loss and eating following a targeted chemoradiation protocol consisting of a selective supradose of intra-arterial cisplatin (150 mg/m2 per week for 4 weeks) with parenteral sodium thiosulfate and external-beam irradiation (1.8-2.0 Gy per fraction per day for 35 days).

Subjects and Design  Forty-seven patients with advanced head and neck cancer treated with a targeted chemoradiation protocol were monitored for weight and eating status before treatment and as long as 18 months after treatment.

Results  A statistically significant weight loss (P<.001) occurred during the targeted chemoradiation protocol, with a mean weight ratio of 90% of the starting weight. The ability to eat also declined, with an increase in reported swallowing difficulties and a need for percutaneous endoscopic gastrostomy tubes from 4 (9%) to 12 (26%). There were no significant changes in weight after the initial weight loss. Tumor stage and nodal involvement had no effect on weight loss. At the start of treatment, 18 patients (38%) reported normal eating and 4 (8%) required a feeding tube. By 18 months after treatment, 41 (87%) were eating normally, 34 (72%) reported normal eating, and 6 (13%) required a percutaneous endoscopic gastrostomy tube.

Conclusions  Patients undergoing a targeted chemoradiation protocol for head and neck cancer lost about 10% of their pretreatment weight and had a decline in eating ability. Difficulty swallowing during the treatment may be due to adverse effects such as mucositis and nausea. By 18 months after therapy, most were able to eat normally and maintain their weight.


From the Departments of Otolaryngology–Head and Neck Surgery (Drs Newman, Vieira, Schwiezer, Samant, Woodson, and Robbins) and Radiation Oncology (Dr Kumar), University of Tennessee, College of Medicine, Memphis, and the Eye and Ear Institute, Pittsburgh, Pa (Dr Murry).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Enteral Nutrition Support of Head and Neck Cancer Patients
Raykher et al.
Nutr Clin Pract 2007;22:68-73.
ABSTRACT | FULL TEXT  

Variables Associated With Feeding Tube Placement in Head and Neck Cancer.
Cheng et al.
Arch Otolaryngol Head Neck Surg 2006;132:655-661.
ABSTRACT | FULL TEXT  

RADPLAT: An Alternative to Surgery?
Alkureishi et al.
The Oncologist 2006;11:469-480.
ABSTRACT | FULL TEXT  

Decreased Short- and Long-term Swallowing Problems With Altered Radiotherapy Dosing Used in an Organ-Sparing Protocol for Advanced Pharyngeal Carcinoma
Smith et al.
Arch Otolaryngol Head Neck Surg 2004;130:831-836.
ABSTRACT | FULL TEXT  

Voice and Swallowing in Patients Enrolled in a Larynx Preservation Trial
Carrara-de Angelis et al.
Arch Otolaryngol Head Neck Surg 2003;129:733-738.
ABSTRACT | FULL TEXT  

NUTRITION AS A MEDIATOR IN THE RELATION BETWEEN ORAL AND SYSTEMIC DISEASE: ASSOCIATIONS BETWEEN SPECIFIC MEASURES OF ADULT ORAL HEALTH AND NUTRITION OUTCOMES
Ritchie et al.
Crit. Rev. Oral Biol. Med. 2002;13:291-300.
ABSTRACT | FULL TEXT  

Bone or Cartilage Invasion by Advanced Head and Neck Cancer: Intra-arterial Supradose Cisplatin Chemotherapy and Concomitant Radiotherapy for Organ Preservation
Samant et al.
Arch Otolaryngol Head Neck Surg 2001;127:1451-1456.
ABSTRACT | FULL TEXT  

The Evolving Role of Combined Modality Therapy in Head and Neck Cancer
Robbins
Arch Otolaryngol Head Neck Surg 2000;126:265-269.
FULL TEXT  

Long-term Swallowing Problems After Organ Preservation Therapy With Concomitant Radiation Therapy and Intravenous Hydroxyurea: Initial Results
Smith et al.
Arch Otolaryngol Head Neck Surg 2000;126:384-389.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.